ofatumumab

ofatumumab
A monoclonal antibody being studied in the treatment of certain types of B-cell cancers including chronic lymphocytic leukemia (CLL) and follicular non-Hodgkin lymphoma. Monoclonal antibodies are made in the laboratory and can locate and bind to substances in the body, including cancer cells. Ofatumumab binds to CD20, a protein on the surface of normal B cells and most B-cell tumors. Also called HuMax-CD20.

English dictionary of cancer terms . 2015.

Игры ⚽ Нужно сделать НИР?

Look at other dictionaries:

  • Ofatumumab — Nombre (IUPAC) sistemático Ofamutumab Identificadores …   Wikipedia Español

  • Ofatumumab — ? Monoclonal antibody Type Whole antibody Source Human Target CD20 Clinical data AHFS/Drugs.com …   Wikipedia

  • Ofatumumab — Masse/Länge Primärstruktur 146  kDa …   Deutsch Wikipedia

  • ofatumumab — noun A human monoclonal antibody under investigation for the treatment of chronic lymphocytic leukemia and other diseases …   Wiktionary

  • Leucemia linfática crónica — Para la secuenciación del genoma de la LLC, véase Genoma de la leucemia linfática crónica. Leucemia linfática crónica Frote sanguíneo mostrando linfocitos (morados) en una LLC …   Wikipedia Español

  • Rituximab — drugbox mab source = chimeric (mouse/human) target = CD20 CAS number = 174722 31 7 | ATC prefix = L01 | ATC suffix = XC02 | ATC supplemental = | PubChem = | DrugBank = BTD00014 | C=6416 | H=9874 | N=1688 | O=1987 | S=44 | molecular weight =… …   Wikipedia

  • Cetuximab — ? Monoclonal antibody Type Whole antibody Source Chimeric (mouse/human) Target EGF receptor Clinical data AHFS/Drugs.com …   Wikipedia

  • Gemtuzumab ozogamicin — ? Monoclonal antibody Type Whole antibody Source Humanized (from mouse) Target CD33 Clinical data Trade names Mylotarg AHFS/ …   Wikipedia

  • Monoclonal antibody therapy — Each antibody binds only one specific antigen. Monoclonal antibody therapy is the use of monoclonal antibodies (or mAb) to specifically bind to target cells or proteins. This may then stimulate the patient s immune system to attack those cells.… …   Wikipedia

  • Liste von Multiple-Sklerose-Wirkstoffen in der Erprobung — Für die immunmodulierende Langzeittherapie der Multiplen Sklerose sind derzeit acht Medikamente im deutschen Sprachraum zugelassen: drei Beta Interferone, Glatirameracetat, Mitoxantron, Azathioprin, Natalizumab und Fingolimod. Darüber hinaus gibt …   Deutsch Wikipedia

Share the article and excerpts

Direct link
Do a right-click on the link above
and select “Copy Link”